PainReform (PRFX) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
PainReform Ltd. has appointed Eyal Broder as the Interim Chief Financial Officer, succeeding Dr. Ehud Geller, who remains the Executive Chairman and Interim CEO. The company regained compliance with Nasdaq’s minimum bid price requirement after a period of non-compliance. These changes could influence investor confidence as PainReform navigates its financial and operational strategies.
For further insights into PRFX stock, check out TipRanks’ Stock Analysis page.
